Comparative Trial in Compression Therapy in Leg Lymphedema

Not Applicable

Completed

• Conditions: Leg Lymphedema
• Interventions: Other: Regular Compression therapy (Trico bandages); Other: New Compression therapy (C2L bandages)

• Registration Number: NCT00665379
• Lead Sponsor: Nij Smellinghe Hosptial

Brief Summary

The purpose of this trial is to study the effect of the 3M Coban 2 Layer Compression System (hereafter C2L) in the treatment of leg lymphedema compared to the traditional treatment with Trico bandages.

Detailed Description

The goal of this prospective, randomized, controlled trial with CE marked product is to study the effectiveness (volume reduction) of 24-hour compression therapy for lymphedema, comparing C2L and Trico bandaging. Therefore 30 patients with leg lymphedema are included.

Application of marketed compression bandages (C2L or Trico bandages) used for treatment by trained specialists with assessment of the subbandage pressure and volume reduction.

Measurements are carried out at:

Volumetry:

Measurements after 0h, 2h and 24 h by using classic water displacement apparatus.

Pressure:

Measurements after 0h, 2h (pre and post bandage change) and 24 h;

* supine and standing to calculate the SSI;

* supine with and without dorsal flexion.

for the pressure measurement a Kikuhime (large pads) dice is used. At each new bandaging to document the SSI and the effect of dorsiflexion in the supine position

* The subbandage pressure is measured on the medial aspect of the lower leg at the transition of the gastrocnemius muscle into the Achilles' tendon (B1) (Partsch H. et al. Dermatol Surg 2006; 32: 224-233).

* Fix the sensor (sensor and tube sheathed with Cellona Soft Padding)

Statistical analysis; Analysis of variance (ANOVA) comparing volume, supine subbandage pressure with and without dorsiflexion, and SSI for the used bandages

Study Timeline

• Study Start: 2008-04
• Study First Submitted: 2008-04-17
• Study First Submitted QC: 2008-04-22
• Study First Posted: 2008-04-23
• Primary Completion: 2009-04
• Study Completion: 2009-05
• Status Verified: 2012-05
• Last Update Submitted: 2012-05-19
• Last Update Posted: 2012-05-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Gender: male or female
• More than 18 years of age
• Patients with distal lymphedema of the leg requiring multilayer lymphedema bandaging of the leg
• The patient is able to understand the study and is willing to give written informed consent to the study

Exclusion Criteria

• Allergy against one of the used materials
• Proximal lymphedema (involvement of thigh, genitalia)
• Severe systemic diseases causing peripheral oedema
• Acute superficial or deep vein thrombosis
• Arterial occlusive disease (stadium II, III or IV) or arm/leg blood pressure index (ALPI)<0,8
• Local infection in the therapy area
• Auto-immunological disorders or vasculitis
• Use of systemic corticosteroids

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	Regular Compression therapy (Trico bandages)	Regular compression therapy with non elastic trico bandaging
2	New Compression therapy (C2L bandages)	New two layer compression bandage coban 2

Primary Outcome Measures

Name	Time	Method
volume decrease in relation to interface pressure after application of two types of bandages.	enrollment of 30 patients

Secondary Outcome Measures

Name	Time	Method
Pressure drop after 2 hours and 24 hours of bandaging	after application, at 2 hours and 24 hours after application of bandage

Trial Locations

Locations (1)

Nij Smellinghe hospital; 🇳🇱 Drachten, Friesland, Netherlands